Click here for more information about laboratory operations and procedures
Methylenetetrahydrofolate Reductase mutations
|Utilization Guidelines||Tests with long turn-around times (ie. Molecular based tests and Microarrays) should only be requested on an inpatient if the result is going to affect the inpatient management.
If the patient will likely be discharged before the result will be available, the test should be requested after discharge. (NOTE: UCSF Medical Center is not reimbursed for inpatient testing).
An exception to the above may be appropriate if there is a possibility the patient will not survive to be discharged and the information is important for diagnosis and/or family decisions/management (ie. recurrence risk).
|Test group||Thrombosis risk|
|Performed by||Molecular Diagnostics|
|In House Availability||Run 2x per week, Tuesday & Thursday, day shift only|
|Method||PCR and allele-specific probes|
|Collection Instructions||If collecting in citrate, check the expiration date on the label of the blue top vacutainer before drawing the patient.
Do not collect sample in heparin. Keep sample refrigerated for overnight or longer storage.
For UCSF Samples (from remote sites) Click here for sample collection instructions
For NON-UCSF Samples Click here for Requisition form & Account set-up instructions. Note we only do institutional billing.
|Container type||Lavender top Blue (citrate) and Yellow (ACD) tops acceptable|
|Amount to Collect||3 mL blood (Note this volume is sufficient to perform all thrombosis risk factor mutations)|
|Sample type||Whole blood|
|Preferred volume||3 mL blood (Note this volume is sufficient to perform all thrombosis risk factor mutations)|
|Min. Volume||1.5 mL blood|
|UCSF Rejection Criteria||Heparinized (green top) samples.|
|Processing notes||Do not centrifuge the specimen. Store at room temperature. Refrigerated samples are acceptable.|
|Synonyms||Thrombosis risk mutations; MTHFR mutations; Hyperhomocysteinemia; Hypercoagulability; Methylene Tetrahydrofolate Reductase mutations|
|Turn around times||7-10 days|
|Additional information||The MTHFR mutation 677(C-T) has a carrier frequency of 35% in Caucasians and results in a thermolabile protein which decreases the availability of the N-methyltetrahydrofolate required in the remethylation reaction which controls plasma levels of homocysteine. Homozygosity results in mild hyperhomocysteinemia which is felt to be a risk factor for arterial and venous thrombosis. Risk parallels the level of homocysteine in the patient.
If a mutation is detected it is recommended that the patient seek genetic counseling.
This test was developed and its performance characteristics determined by the Clinical Laboratories at the Medical Center at UC San Francisco. It has not been cleared or approved by the U.S. Food and Drug Administration.
|LDT or Mod FDA?||Yes|
|Last Updated||3/13/2013 9:02:26 AM|
If you have additional questions regarding this test, please call: 415-353-1667